Cetaphil Personalizes Skin Regimens With AI Analysis
Cetaphil, a skincare brand owned by Swiss company Galderma, has launched a skin analyzer tool that offers personalized skin assessment scores and regimen recommendations in seconds using artificial intelligence.
With the snap of a bare-faced selfie, the Cetaphil AI Skin Analysis tool's technology compares consumers’ photo to a database of 70,000 diverse skin images to create a personalized report detailing one’s skin type, concerns and proneness to various skin conditions, according to a media release. The tool considers curated insights from eight categories such as acne, redness, hydration, dark spots and wrinkles. The goal is to present consumers with an analysis and results to help them make more informed skincare decisions and purchases.
Cetaphil’s tool is powered by Perfect Corp's AI Skin Analysis technology and aims to provide a clear and digestible user experience on the brand’s U.S. website. It uses skin scanning technology, featuring AI deep-learning technology to deliver precise assessments and recommendations based on each customer's unique skin concerns.
To experience Cetaphil’s skin analysis, consumers can visit Cetaphil.com, scan the designated QR code using a smartphone, and take a selfie to receive a customized skincare routine recommendation.
This offering complements Cetaphil’s existing Skincare Finder, according to Silvina Nordenstohl, Head of U.S. at Galderma, to further help consumers select which of the brand’s 70-some products may be right for them and “take the guesswork out of daily skincare for sensitive skin."
According to a media release, Perfect Corp.'s AI Skin Analysis technology recently underwent validation testing with Dr. Steven R. Feldman, professor of dermatology at the Wake Forest School of Medicine.
"AI skin tech can be a fantastic tool and useful first step in gaining an understanding of one's personal skincare needs,” Feldman said in the release. “Bringing digital skin analysis results to a dermatologist appointment allows patients to have a more meaningful visit and productive conversation."